The webinars, called "Statutory and Regulatory Mandates for Prescribing and Dispensing Controlled Substances in Kentucky," are scheduled for Jan. 15 and 17. They are free, but participants must register by either visiting www.ameritox.com/kentucky or by calling 888-373-2515. Depending on demand, other sessions may be added.
"My goal is for physicians to walk away from these sessions and be better informed on dealing with these key issues," Cordini said.
Ameritox is the nation's leader in Pain Medication Monitoring Solutions SM, offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers the most thorough pain medication monitoring lab process – Rx Guardian SM – with Rx Guardian CDSM, the only pain medication monitoring process with a proprietary normalization algorithm and a reference database of pain patients clinically assessed for adherence. Patient results are compared against this database, helping physicians assess whether patients are taking their pain medications correctly. Monitoring through prescription drug testing helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, Md. with laboratory facilities in Midland, Texas and Greensboro, N.C. Ameritox can be found online at www.ameritox.com, on Twitter @Ameritox, on Facebook at facebook.com/ameritox, and on YouTube at www.youtube.com/ameritox.© 2013 Ameritox Ltd. All rights reserved. Ameritox, Ameritox-Medication Monitoring Solutions, Rx Guardian, Rx Guardian INSIGHT and Rx Guardian CD are trademarks of Ameritox. Other trademarks are the property of their owners. SOURCE Ameritox